Aida Muhic

832 total citations
39 papers, 511 citations indexed

About

Aida Muhic is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aida Muhic has authored 39 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 16 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aida Muhic's work include Glioma Diagnosis and Treatment (24 papers), Medical Imaging Techniques and Applications (9 papers) and Radiomics and Machine Learning in Medical Imaging (8 papers). Aida Muhic is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Medical Imaging Techniques and Applications (9 papers) and Radiomics and Machine Learning in Medical Imaging (8 papers). Aida Muhic collaborates with scholars based in Denmark, Sweden and Germany. Aida Muhic's co-authors include Hans Skovgaard Poulsen, Ian Law, Kirsten Grunnet, Adam E. Hansen, Vibeke A. Larsen, Henrik Larsson, Morten Mau‐Sørensen, Ulrik Lassen, Otto Mølby Henriksen and Michael Lundemann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Aida Muhic

35 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aida Muhic Denmark	14	281	204	153	114	62	39	511
Yasmin Lassen–Ramshad Denmark	14	282 1.0×	142 0.7×	275 1.8×	68 0.6×	39 0.6×	42	565
Adrien Holzgreve Germany	12	202 0.7×	278 1.4×	164 1.1×	125 1.1×	42 0.7×	76	518
Yukui Wei China	10	220 0.8×	76 0.4×	48 0.3×	74 0.6×	38 0.6×	18	408
Krishna Reddy United States	10	169 0.6×	117 0.6×	180 1.2×	76 0.7×	28 0.5×	25	376
Nelson S. Moss United States	14	218 0.8×	65 0.3×	318 2.1×	189 1.7×	34 0.5×	51	485
Michael Lundemann Denmark	13	228 0.8×	329 1.6×	163 1.1×	36 0.3×	45 0.7×	24	583
Michael Rasper Germany	11	88 0.3×	174 0.9×	68 0.4×	116 1.0×	90 1.5×	23	517
Tejan Diwanji United States	12	78 0.3×	226 1.1×	262 1.7×	60 0.5×	42 0.7×	49	483
Stephanie T. Jünger Germany	14	270 1.0×	88 0.4×	228 1.5×	89 0.8×	40 0.6×	32	464
Tanja Schneider Germany	10	77 0.3×	195 1.0×	116 0.8×	56 0.5×	19 0.3×	25	428

Countries citing papers authored by Aida Muhic

Since Specialization

Citations

This map shows the geographic impact of Aida Muhic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aida Muhic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aida Muhic more than expected).

Fields of papers citing papers by Aida Muhic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aida Muhic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aida Muhic. The network helps show where Aida Muhic may publish in the future.

Co-authorship network of co-authors of Aida Muhic

This figure shows the co-authorship network connecting the top 25 collaborators of Aida Muhic. A scholar is included among the top collaborators of Aida Muhic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aida Muhic. Aida Muhic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lukacova, Slávka, et al.. (2025). Evaluating work activity and societal burden in patients with grade 2 IDH-mutant glioma. Neuro-Oncology Practice.

Henriksen, O., Aida Muhic, Michael Lundemann, et al.. (2024). Added prognostic value of DCE blood volume imaging in patients with suspected recurrent or residual glioblastoma—A hybrid [18F]FET PET/MRI study. Neuro-Oncology Advances. 6(1). vdae196–vdae196. 1 indexed citations

Henriksen, Otto Mølby, Lisbeth Marner, Mette Christensen, et al.. (2024). A prospective clinical study of the influence of oral protein intake on [18F]FET-PET uptake and test–retest repeatability in glioma. EJNMMI Research. 14(1). 58–58. 2 indexed citations

Muhic, Aida, Rikke Hedegaard Dahlrot, Charlotte Aaquist Haslund, et al.. (2024). Selection for proton radiotherapy of grade 1–3 glioma patients. Clinical and Translational Radiation Oncology. 48. 100836–100836.

Muhic, Aida, Søren Møller, Thomas Urup, et al.. (2023). The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients. Neuro-Oncology Advances. 5(1). vdad137–vdad137. 2 indexed citations

Stoltze, Ulrik Kristoffer, Thomas van Overeem Hansen, Mads Bak, et al.. (2022). 9p21.3 Microdeletion involving CDKN2A/2B in a young patient with multiple primary cancers and review of the literature. Molecular Case Studies. 8(4). a006164–a006164. 3 indexed citations

Lorenzen, Ebbe Laugaard, Jesper Folsted Kallehauge, Rikke Hedegaard Dahlrot, et al.. (2021). A national study on the inter-observer variability in the delineation of organs at risk in the brain. Acta Oncologica. 60(11). 1548–1554. 10 indexed citations

Hansen, Christian Rønn, Rikke Hedegaard Dahlrot, Charlotte Aaquist Haslund, et al.. (2021). Treatment plan comparison of proton vs photon radiotherapy for lower-grade gliomas. Physics and Imaging in Radiation Oncology. 20. 98–104. 13 indexed citations

Møller, Grith, et al.. (2021). N-3 fatty acid EPA supplementation in cancer patients receiving abdominal radiotherapy - A randomised controlled trial. Clinical Nutrition ESPEN. 43. 130–136. 9 indexed citations

10.

Rosenschöld, Per Munck af, Ian Law, Silke Engelholm, et al.. (2018). Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients. Radiotherapy and Oncology. 130. 149–155. 10 indexed citations

11.

Galldiks, Norbert, Veronika Dunkl, Garry Ceccon, et al.. (2018). Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine. European Journal of Nuclear Medicine and Molecular Imaging. 45(13). 2377–2386. 41 indexed citations

12.

Lundemann, Michael, Junia C. Costa, Ian Law, et al.. (2017). Patterns of failure for patients with glioblastoma following O-(2-[ 18 F]fluoroethyl)- L -tyrosine PET- and MRI-guided radiotherapy. Radiotherapy and Oncology. 122(3). 380–386. 23 indexed citations

13.

Costa, Junia C., et al.. (2016). PO-0651: Pattern of failure in glioblastoma patients after FET-PET and MRI-guided chemo-radiotherapy. Radiotherapy and Oncology. 119. S304–S304. 1 indexed citations

14.

Henriksen, Otto Mølby, Vibeke A. Larsen, Aida Muhic, et al.. (2015). Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [18F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience. European Journal of Nuclear Medicine and Molecular Imaging. 43(1). 103–112. 53 indexed citations

15.

Ruhlmann, Christina H., Trine Zeeberg Iversen, Meena Okera, et al.. (2015). Multinational study exploring patients’ perceptions of side-effects induced by chemo-radiotherapy. Radiotherapy and Oncology. 117(2). 333–337. 22 indexed citations

16.

Hofland, Kenneth Francis, Steinbjørn Hansen, Morten Mau‐Sørensen, et al.. (2014). Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study. Acta Oncologica. 53(7). 939–944. 24 indexed citations

17.

Muhic, Aida, Hans Skovgaard Poulsen, Morten Mau‐Sørensen, Kirsten Grunnet, & Ulrik Lassen. (2012). Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme. Journal of Neuro-Oncology. 111(2). 205–212. 48 indexed citations

18.

Lock‐Andersen, Jørgen, Karin Dahlstrøm, Krzysztof T. Drzewiecki, et al.. (2011). Rising incidence of Merkel cell carcinoma. Journal of Plastic Surgery and Hand Surgery. 45(6). 274–280. 36 indexed citations

19.

Jensen, Lars Henrik, Henrik Harling, Mikael Jensen, et al.. (2009). Clinical outcome in 520 consecutive Danish rectal cancer patients treated with short course preoperative radiotherapy. European Journal of Surgical Oncology. 36(3). 237–243. 8 indexed citations

20.

Bülow, S, Lars Henrik Jensen, Henrik Harling, et al.. (2009). A national cohort study of long‐course preoperative radiotherapy in primary fixed rectal cancer in Denmark. Colorectal Disease. 12(7Online). e18–23. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact